Beta-blocker therapy for long QT syndrome and catecholaminergic polymorphic ventricular tachycardia: Are all beta-blockers equivalent?

Affiliations

¹ Mayo Clinic, Rochester, Minnesota. Electronic address: esenerth@hrsonline.org.
² Fondazione Salvatore Maugeri, Pavia, Italy.
³ Stanford University, Palo Alto, California.
⁴ Lankenau Medical Center, Wynnewood, Pennsylvania.
⁵ James Cook University Hospital, Middlesbrough, United Kingdom.
⁶ Weill Cornell Medical College, New York, New York.
⁷ Boston Children's Hospital, Boston, Massachusetts.
⁸ Washington University, St. Louis, Missouri.
⁹ Medical University of South Carolina, Charleston, South Carolina.

Review

Michael J Ackerman et al. Heart Rhythm. 2017 Jan.

. 2017 Jan;14(1):e41-e44.

doi: 10.1016/j.hrthm.2016.09.012. Epub 2016 Sep 19.

¹ Mayo Clinic, Rochester, Minnesota. Electronic address: esenerth@hrsonline.org.
² Fondazione Salvatore Maugeri, Pavia, Italy.
³ Stanford University, Palo Alto, California.
⁴ Lankenau Medical Center, Wynnewood, Pennsylvania.
⁵ James Cook University Hospital, Middlesbrough, United Kingdom.
⁶ Weill Cornell Medical College, New York, New York.
⁷ Boston Children's Hospital, Boston, Massachusetts.
⁸ Washington University, St. Louis, Missouri.
⁹ Medical University of South Carolina, Charleston, South Carolina.

No abstract available

Keywords: Beta-blockers; Catecholaminergic polymorphic ventricular tachycardia; Long QT syndrome; Nadolol; Sudden death.

Publication types